• Title/Summary/Keyword: Numb chin syndrome

Search Result 4, Processing Time 0.019 seconds

A Case Report of Numb Chin Syndrome with Facial Pain Caused by Diffuse Large B-Cell Lymphoma (미만성 큰 B-세포 림프종에 의해 발생한 안면 통증을 동반한 Numb Chin Syndrome 증례)

  • Jung, Jae-Kwang;Hur, Yun-Kyung;Choi, Jae-Kap
    • Journal of Oral Medicine and Pain
    • /
    • v.36 no.4
    • /
    • pp.253-259
    • /
    • 2011
  • Numb chin syndrome, is a rare neuropathy, characterized by facial and oral numbness restricted to the distribution of the mental nerve. Even though this neuropathy is uncommon, but this still has an important clinical meaning because it can be related with a malignancy. Because orofacial symptoms can even present the first clinical feature of a malignancy, dentists should pay careful attention to their meaning and importance to detect the malignant tumor early. Moreover, patients who present with a sudden numbness on chin should be investigated for the undiagnosed malignancy. In this report, we described a patient with stabbing orofacial pain and numbness of chin who was diagnosed with diffuse large B-cell lymphoma and placed the importance on the diagnosis of NCS.

A Case of Metastatic Non-small Cell Lung Cancer Presenting with Numb Chin Syndrome (Numb chin 증후군으로 발현한 전이성 비소세포 폐암 1예)

  • Park, Won-Chul;Kim, Kyung-Duk;Shin, Sang-Hyo;Lim, Jae-Min;Bae, Sung-Jin;Im, Joo-Hyuk;Lim, Chae-Man;Lee, Sang-Do;Kim, Dong-Soon;Kim, Won-Dong;Kim, Woo-Sung
    • Tuberculosis and Respiratory Diseases
    • /
    • v.53 no.1
    • /
    • pp.46-51
    • /
    • 2002
  • Numb chin syndrome is a rare clinical manifestation, characterized by focal sensory loss and paresthesia of the chin. It is more often associated with cancer than with benign disorders, and can be the first manifestation of a cancer. A 60-year-old man presented with focal numbness of right chin and gingiva for 10 days. Chest computed tomograghy showed a 3 cm sized mass on the distal left main- stem bronchus. Squamous cell carcinoma was diagnosed on bronchoscopic biopsy. However, bony metastasis of mandible was not evident on reontgenogram, CT scan, bone scintigram and positron emission tomography. Despite the chemotherapy with three cycles of paclitaxel and cisplatinum, the cancer was progressed and pain on the right chin was developed 4 months later. Bone scintigram showed multiple bony metastasis including mandible. Here we report this case with a brief review of the appropriate literature.

Numb Chin Syndrome as the First Symptom of Diffuse Large B-cell Lymphoma

  • Oh, Duwon;Woo, Keoncheol;Kim, Seong Taek;Ahn, Hyung Joon;Choi, Jong-Hoon;Kwon, Jeong-Seung
    • Journal of Oral Medicine and Pain
    • /
    • v.41 no.4
    • /
    • pp.200-204
    • /
    • 2016
  • Numb chin syndrome, or mental neuropathy is a rare sensory neuropathy characterized by abnormal sensation such as hypoesthesia, paresthesia, or dysesthesia in the chin and lower lip innervated by the mental nerve. Sensory neuropathy of mental nerve is somewhat familiar to dentists because it can occur following nerve damage by trauma or dental treatment such as implant surgery or third molar extraction. It can also result from dental causes including abscess or osteomyelitis. However, it can be the first sign of the systemic disease or malignancy if it is not related to dental causes. In this study, we present the case of a patient who present with hypoesthesia and pain in chin area without other symptoms and is later diagnosed with diffuse large B-cell lymphoma.

Prostate adenocarcinoma mandibular metastasis associated with numb chin syndrome: a case report

  • Kim, Il-Kyu;Lee, Dong-Hwan;Cho, Hyun-Young;Seo, Ji-Hoon;Park, Seung-Hoon;Kim, Joon-Mee
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.42 no.5
    • /
    • pp.301-306
    • /
    • 2016
  • The purpose of this study is to report a rare case of mandibular adenocarcinoma that was diagnosed due to metastasis from the prostate. Numb chin syndrome (NCS), which was associated with this case, is also discussed. Computed tomography (CT) and an intraoral incisional biopsy of the left mandibular area were performed. Urology consultation, hormone therapy, chemotherapy and follow-up radiographic images were administered. Histological examination of the incised specimen revealed moderately differentiated adenocarcinoma. The Gleason score was 8 (primary 4/secondary 4). Immunohistochemical features and radiographic results confirmed the diagnosis of metastasis from prostate adenocarcinoma, moderately differentiated. The patient's prostate-specific antigen (PSA) level was very high. After hormone treatment, the patient's PSA levels dropped gradually. Seventeen months later, in May 2015, the PSA level was elevated. The 18-month follow-up CT image indicated that the patient's condition was aggravated. Docetaxel chemotherapy was started in June 2015 (18 months later), and the sixth cycle of the therapy is in progress. Oral metastases that originate from prostate adenocarcinoma are rare and can induce various periosteal reactions. Hormone therapy, chemotherapy and close follow-up could be additional, appropriate treatment, and were applied in this case. Finally, NCS is a valuable indicator of metastatic disease in the mandible.